ARCH Venture Partners XII, LLC Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
15
Insider Buys Sum
$25.93M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of ARCH Venture Partners XII, LLC

Biography of ARCH Venture Partners XII, LLC

No biography is available at this moment.

2025-10-27PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
1.92M
1.3366%
$2.61$5M-31.23%
2025-08-01PurchasePrime Medicine, Inc.
PRME
10 percent owner
3.03M
1.988%
$3.30$10M-9.03%
2024-02-15PurchasePrime Medicine, Inc.
PRME
10 percent owner
3.2M
4.6348%
$6.25$20M-43.72%
2023-11-14PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
3,357
0.0025%
$11.98$40,217+3.37%
2023-11-13PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
31,653
0.0232%
$11.75$371,923+2.51%
2023-11-10PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
17,275
0.0124%
$11.49$198,481+5.87%
2023-11-09PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
31,079
0.0204%
$10.53$327,262+15.57%
2023-11-08PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
92,251
0.0634%
$11.03$1.02M+15.05%
2023-11-07PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
30,192
0.0216%
$11.50$347,208+5.26%
2023-11-06PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
43,082
0.031%
$11.55$497,597+6.66%
2023-11-03PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
22,420
0.0159%
$11.38$255,140+2.7%
2023-09-29PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
34,560
0.0301%
$13.98$483,149-15.59%
2023-09-28PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
41,951
0.0351%
$13.44$563,699-9.91%
2023-09-27PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
24,504
0.0188%
$12.31$301,644+0.76%
2023-09-26PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
34,000
0.0248%
$11.73$398,820+1.71%
2023-09-25PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
60,740
0.0424%
$11.22$681,464+4.43%
2023-09-22PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
40,000
0.0277%
$11.14$445,600+7.62%
Total: 17
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.